Inventor
SAMUEL E. METOBO
Inventor
US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
A61KPreparations for medical, dental or toiletry purposes22%
C07BGeneral methods of organic chemistry14%
C07KPeptides8%
C07CAcyclic or carbocyclic compounds3%
PatentTitleYear
12,590,062PD-1/PD-L1 inhibitors202612,377,100Toll like receptor modulator compounds202512,338,220Antiviral pyrazolopiridinone compounds202512,338,233PD-1/Pd-L1 inhibitors202512,269,812PD-1/PD-L1 inhibitors202512,037,342Substituted eneoxindoles and uses thereof202411,667,613Antiviral pyrazolopyridinone compounds202311,555,029PD-1/PD-L1 inhibitors202311,453,681Substituted eneoxindoles and uses thereof202211,236,085PD-1/PD-L1 inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to GILEAD SCIENCES INC (10)· patent assignee history
2022–2026Based in US· patent location history
2023–2025Patents assigned to NOVARTIS AG (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GILEAD SCIENCES INC | 10 | 2022–2026 |
| NOVARTIS AG | 2 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 10 | 2022–2026 |